Morris Shannon — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Morris Shannon is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $301K.
Profile
Shannon Morris is the Chief Medical Officer of Erasca, Inc., a clinical-stage oncology company focused on RAS/MAPK pathway-driven cancers, as indicated by the SEC filing context. In this role, she leads Erasca’s medical affairs and clinical development efforts to advance the company’s cancer programs and translational research.
Role
Insider
Notability
28/100
Board memberships
Erasca, Inc.
Awards & honors
Leads medical strategy and clinical development for Erasca's RAS/MAPK programs
Oversees medical affairs and translational research initiatives
Shannon Morris is the Chief Medical Officer of Erasca, Inc., a clinical-stage oncology company focused on RAS/MAPK pathway-driven cancers, as indicated by the SEC filing context. In this role, she leads Erasca’s medical affairs and clinical development efforts to advance the company’s cancer programs and translational research.…
Has Morris Shannon been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($301K) across all tracked filings.
Where can I see all of Morris Shannon's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
